Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

The 2020 Presidential Election Will Boost Twitter Stock

By Ian Bezek, InvestorPlace Contributor

It's time to start thinking about the next presidential election. You should consider the possibilities for TWTR and Twitter stock.

Red-Hot Huya Stock Is a Buy … on Every Dip

By Ian Bezek, InvestorPlace Contributor

Huya stock is already up 74% year-to-date. And yet, it can go up even more in due time. Here's why.

Best ETFs for 2019: The iShares MSCI Mexico Capped ETF Is Holding Strong

By Ian Bezek, InvestorPlace Contributor

Against all odds, Mexico's president and Donald Trump are building a strong friendship. This will pay huge dividends for owners of Mexican stocks.

Don’t Buy Into Nike Stock’s Earnings Dip

By Ian Bezek, InvestorPlace Contributor

NKE's recent underwhelming earnings report could be the start of a trend. Here's what you need to know about Nike stock.

Fifth Third Bancorp Stock Is a Strong Buy After Its Recent Plunge

By Ian Bezek, InvestorPlace Contributor

If you're optimistic on the economy's outlook, bank stocks are a great buy. FITB stock looks particularly compelling - here's why.

Starbucks’ Growth Does Not Justify the Premium Price of SBUX Stock

By Ian Bezek, InvestorPlace Contributor

More competition is coming in the form of Burger King's coffee subscription club. But here's the real threat to SBUX stock going forward.

7 Energy Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor

After the stock market's big recovery, energy stocks stand out as a value haven. Here are 7 great names to consider today.

Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons

By Ian Bezek, InvestorPlace Contributor

ABBV stock offers huge reward with its 5.3% dividend yield, and also huge risk with Humira's generic competition. What's the right play?

5 Stocks To Buy for the Happiest Employees

By Ian Bezek, InvestorPlace Contributor

Investors shouldn't overlook employee morale when looking for stocks to buy. Here are five companies doing a great job keeping their workforce happy.

Can You Trust in IBM’s Nearly 5% Dividend?

By Ian Bezek, InvestorPlace Contributor

If the Red Hat purchase doesn't pay off -- and quickly -- IBM stock may be forced to cut its dividend in coming years.

Load More